Please login to the form below
Probuphine
This page shows the latest Probuphine news and features for those working in and with pharma, biotech and healthcare.
FDA gives green light for opioid addiction implant
FDA gives green light for opioid addiction implant. Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... It found that 63% of patients treated with the Probuphine implant had no evidence of illicit opioid use throughout
Latest news
-
FDA panel backs approval of first opioid addiction implant
FDA panel backs approval of first opioid addiction implant. Probuphine has been developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a particular focus on the Probuphine
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Featured jobs
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
Associate Medical Director
-
Salary TBC
- Lead Medical Copywriter, Healthcare Brand Communications, London
-
Excellent package
- Account Manager, Healthcare Advertising
-
Salary TBC
- Experienced Editor, London, Medical Communications
-
Competitive package
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Account Director - Digital
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Account Director – Global Healthcare PR
-
Salary TBC
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Scientific Team Lead
-
Competitive Salary
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Account Director
-
Negotiable
- Director Healthcare PR Communications
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
Subscribe to our email news alerts
- Tackling a formidable foe
- Cancer care – the power of new technologies
- AcelRX’s potent opioid tablets set to win FDA backing for pain relief
- New leader at Medivir after setbacks
- Roche preps new Kadcyla filings after phase 3 trial win
- Porterhouse Medical Group boosts its scientific services team with two new appointments
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Tackling a formidable foe
- Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
- Cancer care – the power of new technologies
- With patient numbers set to soar, how can we make a difference?...
- Redefining communications excellence
- How to be heard in today’s multichannel, multistakeholder, multimedia world...
Quick links
Infographics
